Almuradova D.M., Ravshanova N.B., Abdurakhimov A.I. Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis. sdlijmscr [Internet]. 2026 Mar. 31 [cited 2026 Apr. 19];6(03):82-6. Available from: https://oscarpubhouse.com/index.php/sdlijmscr/article/view/1575